In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to ...
Pfizer (NYSE:PFE) has reportedly agreed to pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company ...
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, ...
Sen. Ron Wyden questions why Pfizer's tax rate over the last few years is significantly less than the U.S. corporate tax rate ...
Related: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac. In a whistleblower complaint filed on Monday, Valisure claimed GSK ...
Pfizer targets $1.5B savings by 2027 with a new cost-cutting plan focusing on operational efficiencies and restructuring. Technical analysis shows bullish momentum for Pfizer's stock, with prices ...
At an industry presentation about dangerous “forever chemicals,” lawyers predicted a wave of lawsuits that could dwarf asbestos litigation, audio from the event revealed. By Hiroko Tabuchi The ...
An Ontario man was considering having his driveway paved and had received a quote from a company for $7,000. So when another ...
LG opens a Business Innovation Center in Englewood Cliffs, to showcase the corporation’s latest technology to its corporate ...
French drug major Sanofi (SNYNF, SNY) announced Tuesday a collaboration with Formation Bio and AI research and deployment company ...
, opens new tab on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it announced last year.
Rookie goalie Arturs Silovs will start in net for the Canucks as Vancouver kicks off a second-round series against the ...